These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 14666612

  • 1. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612
    [Abstract] [Full Text] [Related]

  • 2. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M.
    Clin Cancer Res; 2005 Jan 01; 11(1):259-66. PubMed ID: 15671554
    [Abstract] [Full Text] [Related]

  • 4. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M.
    Clin Cancer Res; 2001 Dec 01; 7(12):4130-5. PubMed ID: 11751512
    [Abstract] [Full Text] [Related]

  • 5. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.
    Clin Cancer Res; 2003 Nov 15; 9(15):5652-9. PubMed ID: 14654548
    [Abstract] [Full Text] [Related]

  • 6. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma.
    Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ, Medeiros LJ.
    Clin Cancer Res; 2003 Mar 15; 9(3):1121-8. PubMed ID: 12631617
    [Abstract] [Full Text] [Related]

  • 7. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M, Dirnhofer S, Nickl A, Hoefler H, Quintanilla-Martínez L, Fend F.
    Mod Pathol; 2001 Oct 15; 14(10):1022-9. PubMed ID: 11598173
    [Abstract] [Full Text] [Related]

  • 8. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schäfer N, Höller TT, Fischer HP, Büttner R, Gütgemann I.
    Hum Pathol; 2007 Nov 15; 38(11):1621-7. PubMed ID: 17651785
    [Abstract] [Full Text] [Related]

  • 9. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul 15; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 10. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I.
    Cancer Res; 2005 Jun 01; 65(11):4485-9. PubMed ID: 15930262
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 01; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma.
    Goto A, Niki T, Moriyama S, Funata N, Moriyama H, Nishimura Y, Tsuchida R, Kato JY, Fukayama M.
    Pathol Int; 2004 Sep 01; 54(9):675-81. PubMed ID: 15363035
    [Abstract] [Full Text] [Related]

  • 14. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.
    Oncogene; 2004 Nov 25; 23(55):8868-75. PubMed ID: 15480426
    [Abstract] [Full Text] [Related]

  • 15. Expression of the components of the Cip/Kip family in malignant lymphoma of the thyroid.
    Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, Kakudo K, Kuma K, Miyauchi A.
    Pathobiology; 2004 Nov 25; 71(3):164-70. PubMed ID: 15051930
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer.
    Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y.
    Oncol Rep; 2004 Feb 25; 11(2):277-84. PubMed ID: 14719054
    [Abstract] [Full Text] [Related]

  • 17. Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma.
    Ito Y, Yoshida H, Nakamura Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Kakudo K, Miyauchi A.
    Pathology; 2005 Jun 25; 37(3):216-9. PubMed ID: 16175894
    [Abstract] [Full Text] [Related]

  • 18. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.
    Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J.
    Nature; 2000 Nov 09; 408(6809):211-6. PubMed ID: 11089976
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH.
    Breast Cancer Res; 2004 Nov 09; 6(4):R308-15. PubMed ID: 15217497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.